Abstract:Quality of life and productivity loss in patients with ankylosing spondylitis using tumor necrosis factor inhibitorsDear Editor,We have read with great interest the article by Lee et al 1 reporting a comprehensive understanding of the real-world treatment patterns of tumor necrosis factor inhibitor (TNFi) in patients with ankylosing spondylitis (AS) and productivity loss, treatment satisfaction, and associated factors. There are 4 TNFi considered in this study, including infliximab, adalimumab, etanercept, and… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.